Diabetes and Psoriasis

Diabetes and Psoriasis: Study on Prevalence, Role of Inflammation and Insulin-resistance

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02366273

Enrollment

425

Registered

2015-02-19

Start date

2015-02-01

Completion date

2018-06-30

Last updated

2022-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Psoriasis

Keywords

Diabetes, Psoriasis, Inflammation, Insulin-resistance

Brief summary

Patients with psoriasis will be evaluated. The investigators will collect personal history, concomitant diseases and in particular the presence of type 2 diabetes mellitus, impaired fasting glucose and impaired glucose tollerance. The aim of the study will be to evaluate if there is a correlation among inflammation, insulin-resistance and psoriasis.

Interventions

OTHERPASI and HOMA index

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* patients with psoriasis

Exclusion criteria

* NA

Design outcomes

Primary

Measure	Time frame
Evaluation of correlation between diabetes and psoriasis	3 years

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026